Pembrolizumab
- 专利权人:
- MERCK SHARP & DOHME
- 发明人:
- 申请号：
- NO2015028
- 公开号：
- NO2015028I1
- 申请日:
- 2015.12.21
- 申请国别(地区):
- NO
- 年份:
- 2016
- 代理人:
- 摘要：
- Antibodies which block the binding of human Programmed Death Receptor 1 (hPD-1) to its ligands (hPD-L1 or hPD-L2) and their variable region sequences are disclosed. A method of increasing the activity (or reducing downmodulation) of an immune response through the PD-1 pathway is also disclosed.
- 来源网站：
- 中国工程科技知识中心
